🔎 Trials Near Me

Hem › Akut myeloid leukemi › Wisconsin › Madison

Kliniska studier för Akut myeloid leukemi i Madison, WI

16 studier för Akut myeloid leukemi söker deltagare vid platser i och runt Madison (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekryterarObservationsstudieFriska volontärer välkomna
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekryterarFas 2
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • William S Middleton VA Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • William S Middleton VA Medical Center, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekryterarFas 2
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ålder 18 till 59 · Alla kön · Uppdaterad 22 sep. 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekryterarFas 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
6 Months – 21 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

RekryterarFas 3
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ålder 1 till 25 · Alla kön · Uppdaterad 4 sep. 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekryterarFas 1/2
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Upp till ålder 22 · Alla kön · Uppdaterad 25 aug. 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekryterarFas 3
  • University of Wisconsin, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT07007312

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekryterarObservationsstudie
  • University of Wisconsin - Madison, Madison
Alla åldrar · Alla kön · Uppdaterad 6 juli 2026 · NCT01351545

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

RekryterarFas 1
  • University of Wisconsin Carbone Cancer Center, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 14 maj 2026 · NCT06222580

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RekryterarFas 1
  • University of Wisconsin Carbone Cancer Center, Madison
Upp till ålder 21 · Alla kön · Uppdaterad 22 apr. 2026 · NCT05101551

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

RekryterarFas 1
  • University of Wisconsin Hospital and Clinics, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 13 mars 2026 · NCT05735184

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

RekryterarFas 1
  • University of Wisconsin Carbone Cancer Center, Madison
7 Months – 21 Years · Alla kön · Uppdaterad 16 okt. 2025 · NCT02508038

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RekryterarFas 1
  • University of Wisconsin Clinical Science Center, Madison
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2025 · NCT06501196

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RekryterarFriska volontärer välkomna
  • University of Wisconsin, Madison
Ålder 18 till 120 · Alla kön · Uppdaterad 25 juli 2025 · NCT05237258

Akut myeloid leukemi-studier i andra städer

Andra studier i Madison

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.